What Is Cutaneous Lymphoma?
Cutaneous lymphomas comprise a rare group of Non-Hodgkins lymphoma that arise primarily in the skin. The Stanford Cutaneous Lymphoma Program is expert in the treatment and investigation of all forms of cutaneous lymphoma, including the relatively more common T-cell and B-cell cutaneous lymphomas.
Stanford Cutaneous Lymphoma Program
The Stanford multispecialty Cutaneous Lymphoma team offers expert treatment for patients with cutaneous lymphomas, including mycosis fungoides, Sezary syndrome, CD30+ lymphoproliferative disorders (lymphomatoid papulosis and anaplastic large cell lymphoma), subcutaneous panniculitis-like T-cell lymphoma, gamma-delta T-cell lymphoma, CD8+ aggressive epidermotropic T-cell lymphoma, NK/T-cell lymphoma, other unspecified cutaneous peripheral T-cell lymphomas, and cutaneous B-cell lymphomas. Our physicians subspecialize in treating these types of cancers, and have extensive expertise in handling the most complicated cases. Care among specialists is tightly integrated.